XHC:CA:TSX-iShares Global Healthcare (CAD Hedged) (CAD)

ETF | Sector Equity |

Last Closing

CAD 74.81

Change

-0.20 (-0.27)%

Market Cap

CAD 0.65B

Volume

3.80K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-02 )

Largest Industry Peers for Sector Equity

Symbol Name Price(Change) Market Cap
TEC:CA TD Global Technology Leaders I..

+0.06 (+0.15%)

CAD 2.91B
ZWU:CA BMO Covered Call Utilities ETF

-0.02 (-0.18%)

CAD 1.94B
XIT:CA iShares S&P/TSX Capped Informa..

+0.35 (+0.61%)

CAD 0.65B
TXF:CA First Asset Tech Giants Covere..

+0.18 (+0.82%)

CAD 0.65B
HTA:CA Harvest Tech Achievers Growth ..

+0.10 (+0.54%)

CAD 0.63B
ZUT:CA BMO Equal Weight Utilities Ind..

-0.10 (-0.44%)

CAD 0.45B
CWW:CA iShares Global Water Common Cl..

-0.59 (-0.99%)

CAD 0.34B
XUT:CA iShares S&P/TSX Capped Utiliti..

-0.11 (-0.38%)

CAD 0.32B
COW:CA iShares Global Agriculture Com..

-0.21 (-0.33%)

CAD 0.28B
ZUH:CA BMO Equal Weight US Health Car..

-0.34 (-0.47%)

CAD 0.27B

ETFs Containing XHC:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Sector Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 12.18% 74% C 55% F
Dividend Return 0.56% 35% F 17% F
Total Return 12.74% 54% F 51% F
Trailing 12 Months  
Capital Gain 15.18% 34% F 41% F
Dividend Return 2.46% 61% D- 42% F
Total Return 17.64% 37% F 42% F
Trailing 5 Years  
Capital Gain 55.40% 57% F 71% C-
Dividend Return 6.91% 52% F 23% F
Total Return 62.31% 60% D- 70% C-
Average Annual (5 Year Horizon)  
Capital Gain 7.63% N/A N/A 63% D
Dividend Return 8.69% N/A N/A 62% D
Total Return 1.05% N/A N/A 37% F
Risk Return Profile  
Volatility (Standard Deviation) 8.58% N/A N/A 85% B
Risk Adjusted Return 101.23% N/A N/A 97% N/A
Market Capitalization 0.65B 94% A 63% D

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

What to not like:
Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.